ZACHARIS, THEODOSSIS MD
Pulmonary Disease · NPI 1205889243 · NEW SMYRNA BEACH, FL
ZACHARIS, THEODOSSIS is a Pulmonary Disease in NEW SMYRNA BEACH, FL, a member of 1 medical group, who billed 38 distinct codes to Medicare Part B in 2024.
Groups: PCCC OF VOLUSIA LLC (NEW SMYRNA BEACH, FL)
Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒
Provider overview · all codes · CY2024
All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.
Procedures billed to Medicare Part B (2024)
Medicare Part B FFS · CY2024 · as published by CMS| Code | Description | Services | Beneficiary-episodes | Avg charge | Avg Medicare payment |
|---|---|---|---|---|---|
| J1010 | Injection, methylprednisolone acetate, 1 mg | premium | premium | premium | premium |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | premium | premium | premium | premium |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | premium | premium | premium | premium |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | premium | premium | premium | premium |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | premium | premium | premium | premium |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | premium | premium | premium | premium |
| 96375 | Injection of additional new drug or substance into vein | premium | premium | premium | premium |
| J1956 | Injection, levofloxacin, 250 mg | premium | premium | premium | premium |
| 94729 | Test to examine how well the lungs exchange gases | premium | premium | premium | premium |
| 94726 | Test to determine lung volumes using sensors | premium | premium | premium | premium |
| 96372 | Injection of drug or substance under skin or into muscle | premium | premium | premium | premium |
| J1335 | Injection, ertapenem sodium, 500 mg | premium | premium | premium | premium |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | premium | premium | premium | premium |
| J0692 | Injection, cefepime hydrochloride, 500 mg | premium | premium | premium | premium |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | premium | premium | premium | premium |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | premium | premium | premium | premium |
| 94664 | Evaluation of use of breathing device | premium | premium | premium | premium |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | premium | premium | premium | premium |
| 99291 | Critical care, first 30-74 minutes | premium | premium | premium | premium |
| 94660 | Therapy procedure using a positive pressure ventilator | premium | premium | premium | premium |
| G0008 | Administration of influenza virus vaccine | premium | premium | premium | premium |
| J1040 | Injection, methylprednisolone acetate, 80 mg | premium | premium | premium | premium |
| 95810 | Sleep study in sleep lab (6 years or older) | premium | premium | premium | premium |
| J1940 | Injection, furosemide, up to 20 mg | premium | premium | premium | premium |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | premium | premium | premium | premium |
| 90661 | Influenza vaccine, trivalent derived from cell cultures | premium | premium | premium | premium |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | premium | premium | premium | premium |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | premium | premium | premium | premium |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | premium | premium | premium | premium |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | premium | premium | premium | premium |
| 99215 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | premium | premium | premium | premium |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | premium | premium | premium | premium |
| 99203 | New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 90653 | Influenza vaccine, inactivated | premium | premium | premium | premium |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | premium | premium | premium | premium |
| 94618 | Test for exercise-induced lung stress | premium | premium | premium | premium |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | premium | premium | premium | premium |
These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.